Last updated on September 2017

Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes


Brief description of study

This is an observational, case-control study evaluating the quantitative level of Septin9 in plasma pre- and post-colectomy in hereditary colorectal cancer (CRC) syndrome patients (Familial Adenomatous Polyposis (FAP), Lynch syndrome (also known as HNPCC), and Multiple Adenomatous Polyposis (MAP, also known as MYK/MYH) cases) and genetically related FAP-family members as controls and references.

Clinical Study Identifier: NCT02198092

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Anil K. Rustgi, MD

University of Pennsylvania
Philadelphia, PA United States
  Connect »